To provide for a limitation on availability of funds for District of Columbia, Federal Payment for Testing and Treatment of HIV/AIDS for fiscal year 2024.
HR 2104 sets a $3 million funding ceiling for the District of Columbia's federal program providing HIV/AIDS testing and treatment services during fiscal year 2024. This bill directly affects the District of Columbia's ability to access federal funds under this specific program. The key provision is a strict limit on available funds, overriding any prior authorizations or appropriations for this purpose. The bill does not alter existing eligibility or service requirements but restricts the maximum amount of federal payment available.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2023
Committee Review
Floor Vote
President
Introduced Mar 29, 2023
Last action Mar 29, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Mar 29, 2023
Committee
Referred to the House Committee on Oversight and Accountability.
lower
Mar 29, 2023
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2104
Scope: US
Hi! I can help you understand HR 2104. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline